다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

AB

Ab Science (AB)

Ab Science

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:EU:AB

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/14	01:08	GlobeNewswire Inc.	AB Science announces issuance of a European patent for masitinib in the treatment of severe mastocytosis with protection until 2036	EU:AB	Ab Science
2024/05/14	01:08	GlobeNewswire Inc.	AB Science announces issuance of a European patent for masitinib in the treatment of severe mastocytosis with protection until 2036	EU:AB	Ab Science
2024/05/14	01:08	GlobeNewswire Inc.	AB Science annonce la délivrance d’un brevet européen pour le masitinib dans le traitement de la mastocytose sévère avec une protection jusqu’en 2036	EU:AB	Ab Science
2024/05/08	01:05	GlobeNewswire Inc.	AB Science:	EU:AB	Ab Science
2024/05/08	01:05	GlobeNewswire Inc.	AB Science : A new publication in the medical journal Muscle & Nerve validates the use of the rate of decline of ALSFR-S score (ΔFS) for the design of clinical studies and the treatment choice for amyotrophic lateral sclerosis (ALS) patient	EU:AB	Ab Science
2024/05/08	01:05	GlobeNewswire Inc.	AB Science : A new publication in the medical journal Muscle & Nerve validates the use of the rate of decline of ALSFR-S score (ΔFS) for the design of clinical studies and the treatment choice for amyotrophic lateral sclerosis (ALS) patient	EU:AB	Ab Science
2024/05/03	02:14	GlobeNewswire Inc.	AB Science : The Paris Court of Appeal confirms the acquittal of the CEO of AB Science, Alain Moussy, and reduces the amount of the financial penalty imposed on AB Science	EU:AB	Ab Science
2024/05/03	02:14	GlobeNewswire Inc.	AB Science : La Cour d’Appel de Paris confirme la mise hors de cause du Président Directeur Général d’AB Science, Alain Moussy, et diminue le montant de la sanction imposée à AB Science	EU:AB	Ab Science
2024/05/03	02:14	GlobeNewswire Inc.	AB Science : The Paris Court of Appeal confirms the acquittal of the CEO of AB Science, Alain Moussy, and reduces the amount of the financial penalty imposed on AB Science	EU:AB	Ab Science
2024/05/01	01:56	GlobeNewswire Inc.	AB Science annonce un léger décalage de la publication de son rapport financier annuel 2023	EU:AB	Ab Science
2024/05/01	01:56	GlobeNewswire Inc.	AB Science announces a slight delay in the publication of its 2023 annual financial report	EU:AB	Ab Science
2024/05/01	01:56	GlobeNewswire Inc.	AB Science announces a slight delay in the publication of its 2023 annual financial report	EU:AB	Ab Science
2024/04/04	01:08	GlobeNewswire Inc.	AB Science annonce que Santé Canada a jugé admissible la demande de réexamen du masitinib dans SLA	EU:AB	Ab Science
2024/04/04	01:08	GlobeNewswire Inc.	AB Science announces that Health Canada has granted eligibility for reconsideration request for masitinib in ALS	EU:AB	Ab Science
2024/03/13	20:58	GlobeNewswire Inc.	AB Science : De nouvelles recherches montrent que le masitinib limite les dommages neuronaux dans un modèle de maladie neurodégénérative d’origine neuroimmune	EU:AB	Ab Science
2024/03/13	20:58	GlobeNewswire Inc.	AB Science: New research shows that masitinib limits neuronal damage in a model of neuroimmune-driven neurodegenerative disease	EU:AB	Ab Science
2024/03/13	20:58	GlobeNewswire Inc.	AB Science: New research shows that masitinib limits neuronal damage in a model of neuroimmune-driven neurodegenerative disease	EU:AB	Ab Science
2024/03/07	23:20	GlobeNewswire Inc.	AB Science provides a summary of the live webcast held on March 4, 2024 giving an update on AB Science development	EU:AB	Ab Science
2024/03/07	23:20	GlobeNewswire Inc.	AB Science propose un résumé de la conférence virtuelle qui s’est tenue le 4 mars 2024, avec pour objectif de faire le point sur le développement d'AB Science	EU:AB	Ab Science
2024/03/07	23:20	GlobeNewswire Inc.	AB Science provides a summary of the live webcast held on March 4, 2024 giving an update on AB Science development	EU:AB	Ab Science
2024/03/07	04:21	GlobeNewswire Inc.	AB Science announces that two financial analysis firms, DNA Finance and In Extenso Finance, have initiated coverage of the Company	EU:AB	Ab Science
2024/03/07	04:21	GlobeNewswire Inc.	AB Science announces that two financial analysis firms, DNA Finance and In Extenso Finance, have initiated coverage of the Company	EU:AB	Ab Science
2024/03/07	04:21	GlobeNewswire Inc.	AB Science annonce l’initiation de la couverture de son titre par deux sociétés d’analyse financières, DNA Finance d’une part, et par In Extenso Finance d’autre part	EU:AB	Ab Science
2024/03/02	02:07	GlobeNewswire Inc.	AB Science tiendra une conférence virtuelle le lundi 4 mars 2024, de 18h30 à 19h30	EU:AB	Ab Science
2024/03/02	02:07	GlobeNewswire Inc.	AB Science will host a live webcast on Monday March 4, 2024, from 6.30pm to 7.30pm CET	EU:AB	Ab Science
2024/03/02	02:07	GlobeNewswire Inc.	AB Science will host a live webcast on Monday March 4, 2024, from 6.30pm to 7.30pm CET	EU:AB	Ab Science
2024/02/29	19:49	GlobeNewswire Inc.	AB Science will host a live webcast on Monday March 4, 2024, from 6.30pm to 7.30pm CET	EU:AB	Ab Science
2024/02/29	19:49	GlobeNewswire Inc.	AB Science tiendra une conférence virtuelle le lundi 4 mars 2024, de 18h30 à 19h30	EU:AB	Ab Science
2024/02/29	19:49	GlobeNewswire Inc.	AB Science will host a live webcast on Monday March 4, 2024, from 6.30pm to 7.30pm CET	EU:AB	Ab Science
2024/02/27	02:32	GlobeNewswire Inc.	AB Science annonce que Santé Canada a émis un Avis de Non-Conformité-Retrait (ANC-R) pour le masitinib dans la SLA	EU:AB	Ab Science

검색 관련기사 보기:EU:AB

1 2 3 4 5 6 7 8 9 10 다음 >>

Financial Select Sector

US Dollar vs Sterling

Health Care Select Sector

US Dollar vs Euro

Deutsche Telekom (QX)

American Express

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관